Methylphenidate and Eszopiclone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate (methylphenidate) and Eszopiclone (eszopiclone). Common drug interactions include muscular weakness among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Methylphenidate and Eszopiclone. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Eszopiclone?

Eszopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 4,258 Eszopiclone users. Check the latest studies of Eszopiclone.



On Jul, 30, 2026

21 people who take Methylphenidate and Eszopiclone together, and have interactions are studied.

Methylphenidate and Eszopiclone drug interactions.

What are the common drug interactions of Methylphenidate and Eszopiclone, by gender? *:

female:

  1. Muscular weakness (muscle weakness)
  2. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Neck pain
  6. Neuralgia (pain in one or more nerves)
  7. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
  8. Night sweats (sweating in night)
  9. Nocturia (the need to get up in the night to urinate)
  10. Oedema (fluid collection in tissue)

male:

  1. Abdominal discomfort
  2. Abnormal dreams
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Head injury
  8. Loss of consciousness
  9. Memory impairment
  10. Muscle spasms (muscle contraction)

What are the common drug interactions of Methylphenidate and Eszopiclone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Bladder discomfort
  2. Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
  3. Nephrocalcinosis (a condition in which calcium levels in the kidneys are increased)
  4. Renal impairment (severely reduced kidney function)
  5. Drug effect prolonged
  6. Facial bones fracture (bone fracture of face)
  7. Fall

40-49:

  1. Road traffic accident
  2. Sinusitis (inflammation of sinus)
  3. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  4. Snoring
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Stress urinary incontinence (leak urine with things like coughing, sneezing or exercise)
  7. Wheezing (a high-pitched whistling sound made while you breath)
  8. Anxiety
  9. Chest pain
  10. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Drug ineffective
  2. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  3. Spinal stenosis (narrowing of spinal column)
  4. Balance disorder
  5. Blood calcium decreased
  6. Blood chloride increased
  7. Blood creatine increased
  8. Blood glucose increased
  9. Blood urea nitrogen/creatinine ratio decreased
  10. Bradycardia (abnormally slow heart action)

60+:

  1. Flatulence (flatus expelled through the anus)
  2. Frequent bowel movements
  3. Skin ulcer
  4. Weight decreased
  5. Initial insomnia (feeling of inadequate or poor-quality sleep)
  6. Limb injury
  7. Lower limb fracture
  8. Muscular weakness (muscle weakness)
  9. Nausea (feeling of having an urge to vomit)
  10. Onychomycosis (fungal infection of the nail)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 61.90%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 57.14%
  3. Drowsiness: 6 people, 28.57%
  4. Stress And Anxiety: 2 people, 9.52%
  5. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and Eszopiclone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylphenidate and Eszopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Eszopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylphenidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eszopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate and eszopiclone (the active ingredients of Methylphenidate and Eszopiclone, respectively), and Methylphenidate and Eszopiclone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: